Previous Close | 46.20 |
Open | 46.55 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's Range | 46.55 - 47.10 |
52 Week Range | 37.90 - 52.00 |
Volume | |
Avg. Volume | 5,433 |
Market Cap | 1.086B |
Beta (5Y Monthly) | 0.78 |
PE Ratio (TTM) | 11.83 |
EPS (TTM) | 3.98 |
Earnings Date | Nov 08, 2022 |
Forward Dividend & Yield | 1.60 (3.52%) |
Ex-Dividend Date | Dec 13, 2022 |
1y Target Est | 66.20 |
Subscribe to Yahoo Finance Plus to view Fair Value for RIN.PA
COMBINED ANNUAL GENERAL MEETING 2022 Approval of the financial statements for 2021-2022, showing total net income of 95.4 million eurosA net dividend of 1.60 euros per share, constant in nominal value compared to the previous fiscal yearConfirmation of the objectives for 2022-2023 The Combined Annual General Meeting of Vilmorin & Cie's Shareholders was held on Friday December 9, 2022 in Cournon-d’Auvergne (France), under the chairmanship of Sébastien VIDAL, Chairman and CEO. The Shareholders the
Activity: driven by Field Seeds, sales for activities intended for professional markets rose sharply Objectives for 2022-2023: Vilmorin & Cie confirms its objectives for the fiscal year News: Filing of the Universal Registration Document for 2021-2022Preparation of the Combined Annual General Meeting (Ordinary and Extraordinary) of December 9, 2022 Vilmorin & Cie’s consolidated sales for the first quarter of 2022-2023, closing on September 30, 2022, corresponding to revenue from ordinary activit
Vilmorin & Cie once again demonstrates the resilience of its model by achieving solid commercial and financial performances Proposal of a dividend of 1.60 euros per share at the upcoming Annual General Meeting of Shareholders, in Auvergne News: a new research partnership concerning pulses in Canada Objectives for 2022-2023: business growth of between 6% and 8%* and a current operating margin rate of at least 8% *On a like-for-like basis. Financial statements for fiscal year 2021-2022:Vilmorin &